PolyNovo Limited

PNV

AU000000PNV0

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 02:10:52 2024-07-17 EDT			5-day change	1st Jan Change
2.59 ^AUD	+9.28%		+10.21%	+56.50%

07-08	Spectral AI Partners With PolyNovo to Deploy Burn Wound Diagnostics System in Australia	MT
07-08	Spectral AI, Inc. Announces Collaboration with PolyNovo Limited	CI

Polynovo Limited Appoints Gavin Smith as Joint Company Secretary

January 19, 2017 at 08:12 pm

Polynovo Limited appointed Mr. Gavin Smith as joint company secretary of the company, effective January 20, 2017.

Latest news about PolyNovo Limited

Spectral AI Partners With PolyNovo to Deploy Burn Wound Diagnostics System in Australia	07-08	MT
Spectral AI, Inc. Announces Collaboration with PolyNovo Limited	07-08	CI
PolyNovo's Revenue Climbs 68.6% in April	05-07	MT
Polynovo Gets India OK for Listing of Dermal Scaffold Device on Government e-Portal Marketplace	03-03	MT
Transcript : PolyNovo Limited, H1 2024 Earnings Call, Feb 27, 2024	02-26
PolyNovo Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-26	CI
PolyNovo Secures Largest Single Order Worth AU$1.2 Million; Shares Rise 3%	02-15	MT
PolyNovo Logs Record Monthly Sales in November	12-06	MT
PolyNovo Limited Reports Unaudited Sales Results for the Month of November 2023	12-05	CI
Transcript : PolyNovo Limited - Shareholder/Analyst Call	11-02
Polynovo Secures Additional Funding from BARDA for Burn Treatment Trial	23-10-02	MT
Transcript : PolyNovo Limited, 2023 Earnings Call, Aug 23, 2023	23-08-23
PolyNovo Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-22	CI
Immuron Appoints Paul Brennan as Board Chairman	23-06-30	MT
PolyNovo Limited Reports Revenue Results for the Month and Nine Months Ended 31 March 2023	23-05-01	CI
PolyNovo Limited(ASX:PNV) added to S&P/ASX 200 Index	23-03-20	CI
Polynovo Swings to Net Loss in Fiscal H1 on Employee, R&D Expansion; Shares Fall 4%	23-02-23	MT
Transcript : PolyNovo Limited, H1 2023 Earnings Call, Feb 23, 2023	23-02-22
PolyNovo Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-22	CI
PolyNovo Limited Announces Update on SynPath Diabetic Foot Ulcer Trial	23-02-14	CI
Transcript : PolyNovo Limited - Shareholder/Analyst Call	23-01-16
PolyNovo Limited Provides Unaudited Revenues Results for the First Half 2023	23-01-15	CI
Transcript : PolyNovo Limited Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 07:30 AM	23-01-11
Polynovo to Raise AU$20 Million from Share Purchase Plan	22-12-16	MT
Transcript : PolyNovo Limited - Pre Recorded Special Call	22-12-04

PolyNovo Limited is an Australia-based medical device company, which is focused on advanced wound care that designs, develops, and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. Its solutions include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a synthetic, biodegradable and biocompatible device designed to facilitate the dermis to grow within a patented polyurethane matrix when lost through extensive surgery, trauma or burn. NovoSorb BTM is indicated for use in the management of wounds, including partial and full thickness wounds, pressure ulcers, venous and diabetic ulcers, chronic and vascular ulcers, surgical wounds, trauma wounds and draining wounds. Its development program covers breast sling, hernia, and orthopedic applications. NovoSorb MTX is available in a range of sizes to address acute and chronic dermal wounds and is comprised of a 2mm biodegradable foam with no sealing membrane.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-21 - Q4 2024 Earnings Release (Projected)

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Ratings for PolyNovo Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.37 AUD

Average target price

2.175 AUD

Spread / Average Target

-8.22%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
POLYNOVO LIMITED	+56.50%	1.1B
ABBOTT LABORATORIES	-4.43%	179B
MEDTRONIC PLC	-2.62%	100B
DEXCOM, INC.	-6.87%	46.16B
HOYA CORPORATION	+18.16%	44.81B
CENCORA, INC.	+9.89%	44.38B
METTLER-TOLEDO INTERNATIONAL, INC.	+14.26%	29.53B
TERUMO CORPORATION	+22.31%	25.83B
WEST PHARMACEUTICAL SERVICES, INC.	-7.30%	23.97B
STERIS PLC	+3.73%	22.5B

Other Medical Equipment, Supplies & Distribution